Filing Details
- Accession Number:
- 0001567619-19-003799
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-13 16:41:54
- Reporting Period:
- 2019-02-11
- Accepted Time:
- 2019-02-13 16:41:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1200375 | Codexis Inc | CDXS | Industrial Organic Chemicals (2860) | 710872999 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599677 | James Lalonde | C/O Codexis, Inc. 200 Penobscot Drive Redwood City CA 94063 | Svp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-11 | 8,958 | $21.57 | 142,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-12 | 8,957 | $21.69 | 133,402 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 8, 2017.
- This transaction was executed in multiple trades in prices ranging from $21.41 to $21.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price with the range set forth in this footnote.
- This transaction was executed in multiple trades in prices ranging from $21.55 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price with the range set forth in this footnote.
Billionaire Hedge Funds
